The Global Pulmonary Hypertension Drugs Market is estimated to be valued at USD 8.69 Bn in 2025 and is expected to reach USD 14.23 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032. https://coherentmi01.livepositively.com/pulmonary-hypertension-drugs-market-growth-driven-by-innovative-therapies/new=1